|
|
|
40
|
3681G
|
NALOXONE 0.4MG/ML INJ (RTM/PHA)
|
NALOXONE
|
NALOXONE
|
10X1ML
|
BQ
|
49.25
|
4.925
|
INJECTION
|
|
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat B
|
IV
|
|
OPIATE ANTAGONISTS
|
2023-02-22
|
|
|
|
41
|
3681G
|
NALOXONE 0.4MG/ML INJ (RTM) (B)
|
NALOXONE
|
NALOXONE
|
10X1ML
|
B
|
57.3
|
5.7302
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE ANTAGONISTS
|
|
|
|
|
42
|
3681G
|
NALOXONE 0.4MG/ML INJ (RTM)
|
NALOXONE
|
NALOXONE
|
10X1ML
|
B
|
40.77
|
4.08
|
AMPG
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2026-04-01
|
|
|
IV
|
0
|
OPIATE ANTAGONISTS
|
|
|
|
|
41
|
3681Q
|
N-XONE 0.4MG/ML INJ (VEV) NALOXONE (B)
|
NALOXONE
|
N-XONE
|
10X1ML
|
B
|
47.3
|
4.7299
|
AMP
|
0
|
BOX
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2810
|
OPIATE ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE ANTAGONISTS
|
|
|
|
|
40
|
3681T
|
NALOXONE 0.4MG/ML INJ (MON/PHA)
|
NALOXONE
|
NALOXONE
|
5X1ML
|
BQ
|
13.54
|
2.71
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
3681T
|
NALOXONE 0.4MG/ML INJ (MON/PHA)
|
NALOXONE
|
NALOXONE
|
5X1ML
|
BQ
|
13.54
|
2.708
|
INJECTION
|
|
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2023-03-20
|
2024-03-31
|
Delete from contract
|
IV
|
|
OPIATE ANTAGONISTS
|
2023-02-14
|
|
|
|
42
|
3681T
|
NALOXONE 0.4MG/ML INJ (MON)
|
NALOXONE
|
NALOXONE
|
5X1ML
|
B
|
16.01
|
3.20
|
AMPG
|
0
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2026-04-01
|
|
|
IV
|
0
|
OPIATE ANTAGONISTS
|
|
|
|
|
40
|
3681V
|
NALOXONE 0.4MG/ML AMP (RTM/PHA)
|
NALOXONE
|
NALOXONE
|
10'S
|
|
57.86
|
5.786
|
AMPOULE GLAS
|
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2023-03-20
|
2024-03-31
|
Price Change
|
IV/IM
|
|
OPIATE ANTAGONISTS
|
2023-02-14
|
|
|
|
41
|
3681W
|
NALOXONE 0.4MG/ML INJ (OMG) (B)
|
NALOXONE
|
NALOXONE
|
10X1ML
|
B
|
47.35
|
4.7353
|
VIAL
|
0
|
BOX
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
2810
|
OPIATE ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV/IM/SC
|
0
|
OPIATE ANTAGONISTS
|
|
|
|
|
42
|
3681W
|
NALOXONE 0.4MG/ML INJ (OMG)
|
NALOXONE
|
NALOXONE
|
10X1ML
|
B
|
52.19
|
5.22
|
VIAL
|
0
|
VIAL
|
OMG
|
OMEGA
|
COL
|
AVENTA BARBADOS
|
|
2810
|
OPIATE ANTAGONISTS
|
2026-04-01
|
|
|
IV/IM/SC
|
0
|
OPIATE ANTAGONISTS
|
|